SCHEMBL4333325

SCHEMBL4333325

COc1ccc(NC(=O)OCc2cccc(CC(C(=O)O)C(=O)O)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.54
LDHA P00338 1/20 0.52
RAB9A P51151 3/20 0.49
TP53 P04637 3/20 0.49
MAPT P10636 2/20 0.49
NPC1 O15118 2/20 0.49
MTNR1B P49286 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
ATM Q13315 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
MGLL Q99685 1/20 0.47
TSHR P16473 1/20 0.47
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13810338 0.93 RAB9A (0.49) FPR2RAB9ATP53MAPTNPC1
SCHEMBL4333262 0.89 USP2 (0.54) RAB9ATP53MAPTNPC1MTNR1B
SCHEMBL4334130 0.88 LMNA (0.56) FPR2LDHARAB9ATP53MAPT
SCHEMBL4338093 0.88 MEN1 (0.56) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL4341257 0.87 MGLL (0.60) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL4328737 0.87 FPR2 (0.48) FPR2RAB9ATP53MAPTNPC1
SCHEMBL4341927 0.85 MEN1 (0.53) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
SCHEMBL13810333 0.84 MGLL (0.56) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL1223807 0.83 RAB9A (0.67) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL4334358 0.83 LDHA (0.52) FPR2LDHARAB9ATP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 FPR2 632/4885LDHA 745/4885RAB9A 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.